BioCatalystWatch
ERASWorkspace / ERAS / OverviewCompany library
Price
Market cap
Next catalystExpected 2H 2026ERAS-4001 — BOREALIS-1 · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
Upcoming / outlook

ERAS-4001

Small molecule

KRAS

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ERAS-4001

Small molecule

KRAS

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
Upcoming / outlook

ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved

Other pipelines

ERAS-0015

Active RAS × Cyclophilin A (CYPA)

PreINDP1P2P3FilingApproved
ERAS-601

Small molecule

SHP2

PreINDP1P2P3FilingApproved

History / paused

BRAF × CRAF

EGFR (D2/D3)

ERAS-601

Small molecule

SHP2

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ERAS SEC archive